Cargando…
CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity
ATP and adenosine have emerged as important signaling molecules involved in vascular remodeling, retinal functioning and neurovascular coupling in the mammalian eye. However, little is known about the regulatory mechanisms of purinergic signaling in the eye. Here, we used three-dimensional multiplex...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881442/ https://www.ncbi.nlm.nih.gov/pubmed/35212809 http://dx.doi.org/10.1007/s00018-022-04187-4 |
_version_ | 1784659466477633536 |
---|---|
author | Losenkova, Karolina Takeda, Akira Ragauskas, Symantas Cerrada-Gimenez, Marc Vähätupa, Maria Kaja, Simon Paul, Marius L. Schmies, Constanze C. Rolshoven, Georg Müller, Christa E. Sandholm, Jouko Jalkanen, Sirpa Kalesnykas, Giedrius Yegutkin, Gennady G. |
author_facet | Losenkova, Karolina Takeda, Akira Ragauskas, Symantas Cerrada-Gimenez, Marc Vähätupa, Maria Kaja, Simon Paul, Marius L. Schmies, Constanze C. Rolshoven, Georg Müller, Christa E. Sandholm, Jouko Jalkanen, Sirpa Kalesnykas, Giedrius Yegutkin, Gennady G. |
author_sort | Losenkova, Karolina |
collection | PubMed |
description | ATP and adenosine have emerged as important signaling molecules involved in vascular remodeling, retinal functioning and neurovascular coupling in the mammalian eye. However, little is known about the regulatory mechanisms of purinergic signaling in the eye. Here, we used three-dimensional multiplexed imaging, in situ enzyme histochemistry, flow cytometric analysis, and single cell transcriptomics to characterize the whole pattern of purine metabolism in mouse and human eyes. This study identified ecto-nucleoside triphosphate diphosphohydrolase-1 (NTPDase1/CD39), NTPDase2, and ecto-5′-nucleotidase/CD73 as major ocular ecto-nucleotidases, which are selectively expressed in the photoreceptor layer (CD73), optic nerve head, retinal vasculature and microglia (CD39), as well as in neuronal processes and cornea (CD39, NTPDase2). Specifically, microglial cells can create a spatially arranged network in the retinal parenchyma by extending and retracting their branched CD39(high)/CD73(low) processes and forming local “purinergic junctions” with CD39(low)/CD73(−) neuronal cell bodies and CD39(high)/CD73(−) retinal blood vessels. The relevance of the CD73–adenosine pathway was confirmed by flash electroretinography showing that pharmacological inhibition of adenosine production by injection of highly selective CD73 inhibitor PSB-12489 in the vitreous cavity of dark-adapted mouse eyes rendered the animals hypersensitive to prolonged bright light, manifested as decreased a-wave and b-wave amplitudes. The impaired electrical responses of retinal cells in PSB-12489-treated mice were not accompanied by decrease in total thickness of the retina or death of photoreceptors and retinal ganglion cells. Our study thus defines ocular adenosine metabolism as a complex and spatially integrated network and further characterizes the critical role of CD73 in maintaining the functional activity of retinal cells. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04187-4. |
format | Online Article Text |
id | pubmed-8881442 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-88814422022-03-02 CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity Losenkova, Karolina Takeda, Akira Ragauskas, Symantas Cerrada-Gimenez, Marc Vähätupa, Maria Kaja, Simon Paul, Marius L. Schmies, Constanze C. Rolshoven, Georg Müller, Christa E. Sandholm, Jouko Jalkanen, Sirpa Kalesnykas, Giedrius Yegutkin, Gennady G. Cell Mol Life Sci Original Article ATP and adenosine have emerged as important signaling molecules involved in vascular remodeling, retinal functioning and neurovascular coupling in the mammalian eye. However, little is known about the regulatory mechanisms of purinergic signaling in the eye. Here, we used three-dimensional multiplexed imaging, in situ enzyme histochemistry, flow cytometric analysis, and single cell transcriptomics to characterize the whole pattern of purine metabolism in mouse and human eyes. This study identified ecto-nucleoside triphosphate diphosphohydrolase-1 (NTPDase1/CD39), NTPDase2, and ecto-5′-nucleotidase/CD73 as major ocular ecto-nucleotidases, which are selectively expressed in the photoreceptor layer (CD73), optic nerve head, retinal vasculature and microglia (CD39), as well as in neuronal processes and cornea (CD39, NTPDase2). Specifically, microglial cells can create a spatially arranged network in the retinal parenchyma by extending and retracting their branched CD39(high)/CD73(low) processes and forming local “purinergic junctions” with CD39(low)/CD73(−) neuronal cell bodies and CD39(high)/CD73(−) retinal blood vessels. The relevance of the CD73–adenosine pathway was confirmed by flash electroretinography showing that pharmacological inhibition of adenosine production by injection of highly selective CD73 inhibitor PSB-12489 in the vitreous cavity of dark-adapted mouse eyes rendered the animals hypersensitive to prolonged bright light, manifested as decreased a-wave and b-wave amplitudes. The impaired electrical responses of retinal cells in PSB-12489-treated mice were not accompanied by decrease in total thickness of the retina or death of photoreceptors and retinal ganglion cells. Our study thus defines ocular adenosine metabolism as a complex and spatially integrated network and further characterizes the critical role of CD73 in maintaining the functional activity of retinal cells. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04187-4. Springer International Publishing 2022-02-25 2022 /pmc/articles/PMC8881442/ /pubmed/35212809 http://dx.doi.org/10.1007/s00018-022-04187-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Losenkova, Karolina Takeda, Akira Ragauskas, Symantas Cerrada-Gimenez, Marc Vähätupa, Maria Kaja, Simon Paul, Marius L. Schmies, Constanze C. Rolshoven, Georg Müller, Christa E. Sandholm, Jouko Jalkanen, Sirpa Kalesnykas, Giedrius Yegutkin, Gennady G. CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity |
title | CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity |
title_full | CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity |
title_fullStr | CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity |
title_full_unstemmed | CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity |
title_short | CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity |
title_sort | cd73 controls ocular adenosine levels and protects retina from light-induced phototoxicity |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881442/ https://www.ncbi.nlm.nih.gov/pubmed/35212809 http://dx.doi.org/10.1007/s00018-022-04187-4 |
work_keys_str_mv | AT losenkovakarolina cd73controlsocularadenosinelevelsandprotectsretinafromlightinducedphototoxicity AT takedaakira cd73controlsocularadenosinelevelsandprotectsretinafromlightinducedphototoxicity AT ragauskassymantas cd73controlsocularadenosinelevelsandprotectsretinafromlightinducedphototoxicity AT cerradagimenezmarc cd73controlsocularadenosinelevelsandprotectsretinafromlightinducedphototoxicity AT vahatupamaria cd73controlsocularadenosinelevelsandprotectsretinafromlightinducedphototoxicity AT kajasimon cd73controlsocularadenosinelevelsandprotectsretinafromlightinducedphototoxicity AT paulmariusl cd73controlsocularadenosinelevelsandprotectsretinafromlightinducedphototoxicity AT schmiesconstanzec cd73controlsocularadenosinelevelsandprotectsretinafromlightinducedphototoxicity AT rolshovengeorg cd73controlsocularadenosinelevelsandprotectsretinafromlightinducedphototoxicity AT mullerchristae cd73controlsocularadenosinelevelsandprotectsretinafromlightinducedphototoxicity AT sandholmjouko cd73controlsocularadenosinelevelsandprotectsretinafromlightinducedphototoxicity AT jalkanensirpa cd73controlsocularadenosinelevelsandprotectsretinafromlightinducedphototoxicity AT kalesnykasgiedrius cd73controlsocularadenosinelevelsandprotectsretinafromlightinducedphototoxicity AT yegutkingennadyg cd73controlsocularadenosinelevelsandprotectsretinafromlightinducedphototoxicity |